You are here
SBIR PHASE I ANTIBODY ARRAY FOR CANCER DETECTION (TOPIC236)
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N43CN0800020
Agency Tracking Number: N43CN0800020
Amount:
$150,000.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Timeline
Solicitation Year:
2008
Award Year:
2008
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
PHARMASEQ, INC.
11 DEER PARK DR, STE 104
MONMOUTH JUNCTION, NJ
08852
United States
DUNS:
027661870
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Wlodek Mandecki
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Business Contact
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Email: mandecki@pharmaseq.com
Research Institution
N/A
Abstract
This Phase I project aims to develop a technology to simultaneously measure three biomarkders for early prostate cancer detection using an electronic radio frequency (RF) light-powered microtransponder. Antigens will be captured using antibodies coupled to the microtransponders and detected using biotinylated antibodies.
* Information listed above is at the time of submission. *